Cargando…
Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer
The treatments provided to and survival of patients with recurrent vs de novo stage IV advanced breast, lung, and colorectal cancer may differ but have not been well studied. Using population-based data from the Cancer Research Network for 4510 patients with advanced breast, lung, or colorectal canc...
Autores principales: | Hassett, Michael J, Uno, Hajime, Cronin, Angel M, Carroll, Nikki M, Hornbrook, Mark C, Ritzwoller, Debra P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024888/ https://www.ncbi.nlm.nih.gov/pubmed/30003196 http://dx.doi.org/10.1093/jncics/pky024 |
Ejemplares similares
-
Regarding the Utility of Unstructured Data and Natural Language
Processing for Identification of Breast Cancer Recurrence
por: Ritzwoller, Debra P., et al.
Publicado: (2021) -
Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study
por: Feigelson, Heather S., et al.
Publicado: (2019) -
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer
por: Cavalleri, Tommaso, et al.
Publicado: (2022) -
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer
por: Su, Chloe C., et al.
Publicado: (2023) -
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)